Sale!

ADAM17 Gene Inflammatory Skin and Bowel Disease Neonatal Type 1 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The ADAM17 Gene Inflammatory Skin and Bowel Disease Neonatal Type 1 NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the ADAM17 gene responsible for severe inflammatory conditions affecting newborns. This specialized test utilizes Next-Generation Sequencing (NGS) technology to detect genetic variations that cause neonatal-onset inflammatory skin lesions, bowel inflammation, and immune system dysregulation. Early detection through this $500 USD test enables timely intervention and personalized treatment strategies for affected infants. The test provides crucial information for families with a history of neonatal inflammatory disorders, helping guide medical management and genetic counseling. Results are typically available within 3-4 weeks from blood sample collection, offering families critical insights into their child’s genetic health and potential treatment options.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

ADAM17 Gene Inflammatory Skin and Bowel Disease Neonatal Type 1 NGS Genetic DNA Test

Comprehensive Genetic Analysis for Neonatal Inflammatory Conditions

The ADAM17 Gene Inflammatory Skin and Bowel Disease Neonatal Type 1 NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying genetic mutations responsible for severe inflammatory disorders in newborns. This specialized test focuses on the ADAM17 gene, which plays a critical role in regulating inflammatory responses and maintaining skin and intestinal barrier integrity. Early detection through this advanced genetic analysis can significantly impact treatment outcomes and quality of life for affected infants.

What This Test Measures and Detects

Our comprehensive NGS-based test specifically targets the ADAM17 gene to identify pathogenic variants associated with neonatal inflammatory skin and bowel disease type 1. The test examines:

  • Complete coding regions of the ADAM17 gene
  • Known pathogenic mutations linked to inflammatory conditions
  • Novel genetic variants that may contribute to disease manifestation
  • Specific nucleotide changes affecting protein function
  • Inheritance patterns for genetic counseling purposes

Who Should Consider This Genetic Test

This specialized genetic test is recommended for newborns and infants presenting with:

  • Unexplained severe skin inflammation and lesions appearing in neonatal period
  • Chronic diarrhea and bowel inflammation unresponsive to conventional treatments
  • Family history of neonatal inflammatory disorders
  • Recurrent infections suggesting immune system dysfunction
  • Failure to thrive accompanied by skin and gastrointestinal symptoms
  • Suspected genetic inflammatory conditions affecting multiple organ systems

Clinical Benefits of Early Genetic Diagnosis

Undergoing the ADAM17 gene test provides numerous advantages for patients and families:

  • Precise Diagnosis: Confirms or rules out ADAM17-related inflammatory disease
  • Personalized Treatment: Enables targeted therapeutic approaches based on genetic findings
  • Family Planning: Provides crucial information for genetic counseling and future pregnancies
  • Prognostic Insights: Helps predict disease course and potential complications
  • Early Intervention: Facilitates timely management to prevent disease progression
  • Research Contribution: Advances understanding of rare genetic inflammatory disorders

Understanding Your Test Results

Our genetic specialists provide comprehensive interpretation of your ADAM17 gene test results:

  • Positive Result: Indicates presence of pathogenic ADAM17 mutation; requires immediate consultation with specialists
  • Negative Result: Suggests ADAM17 gene is normal; other causes should be investigated
  • Variant of Uncertain Significance: Requires additional family studies and clinical correlation
  • Carrier Status: Important for family planning and genetic counseling purposes

All results are accompanied by detailed explanations and recommendations from our certified genetic counselors.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700

Turnaround Time: 3 to 4 Weeks
Sample Type: Blood
Methodology: Next-Generation Sequencing (NGS) Technology

Nationwide Testing Availability

We proudly offer the ADAM17 Gene Inflammatory Skin and Bowel Disease Neonatal Type 1 NGS Genetic DNA Test across our extensive network of testing facilities throughout the United States. Our state-of-the-art laboratories serve patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Each facility maintains the highest standards of genetic testing excellence and patient care.

Take Action for Your Child’s Health

Don’t wait to get answers about your child’s inflammatory symptoms. Early genetic diagnosis can make a significant difference in treatment outcomes and quality of life. Our team of genetic specialists, dermatologists, and immunologists are ready to provide comprehensive care and support throughout the testing process.

Call us today at +1(267) 388-9828 to schedule your genetic counseling session and book the ADAM17 gene test. Our genetic counselors are available to discuss your concerns, explain the testing process, and help you make informed decisions about your child’s healthcare journey.

Remember: Early detection through genetic testing provides the foundation for effective management of complex inflammatory conditions. Take the first step toward understanding your child’s genetic health by contacting our specialized team today.